Autres langues Terumo Corporation

Actions

4543

JP3546800008

Marché Fermé - Japan Exchange Autres places de cotation 08:00:00 05/07/2024			Varia. 5j.	Varia. 1 janv.
2 748 ^JPY	+1,03 %		+3,56 %	+18,89 %

01/07	Le Nikkei japonais réduit ses gains alors que les données de la BOJ augmentent les paris sur la hausse des taux d'intérêt	RE
11/06	Le Nikkei japonais progresse grâce aux actions américaines et aux actions de poids lourds du secteur des semi-conducteurs	RE

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Japan's Nikkei pares gains as BOJ data lifts rate hike bets	01/07
MicroVention Announces the Next Evolution in Stent Innovation: MicroVention’s LVIS™ EVO™ Intraluminal Support Device Now Available in the United States	26/06
Terumo : Announces Voting Results for the Election of Directors	26/06
Japan's Nikkei rises on US stocks, heavyweight chip shares	11/06
Terumo Cardiovascular Announces 510(K) Clearance for the CDI OneView Monitoring System	29/05
Terumo Cardiovascular Announces 510(K) Clearance for the CDI Oneview?? Monitoring System	28/05
Terumo : NICE PUBLISHES A GUIDANCE SUPPORTING THE USE OF SELECTIVE INTERNAL RADIATION THERAPY FOR NEUROENDOCRINE TUMORS WITH LIVER METASTATIS	17/05
Terumo : Q&A Session at the Financial Results Briefing for the Fiscal Year Ended March 31, 2024	16/05
Terumo : Financial Results for the Fiscal Year Ended March 31, 2024 (FY2023)(with note)	15/05
Correction: Terumo’s Profit Up 47% in Fiscal 2024	15/05
Terumo’s Profit Up 47% in Fiscal 2023	15/05
Terumo : The Future of Terumo "Our vision and the path to it"	14/05
Terumo : Financial Results for the Fiscal Year Ended March 31, 2024	14/05
Terumo : Appoints the Candidates for Directors	14/05
Terumo Corporation Reports Earnings Results for the Full Year Ended March 31, 2024	14/05
Terumo Corporation Announces Fiscal Year-End Dividend for the Fiscal Year Ended March 31, 2024, Payable on June 27, 2024; Provides Second Quarter-End and Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2025	14/05
Terumo Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2025	14/05
Penumbra, Inc. : El desvalido de la atención sanitaria	15/04
Penumbra, Inc. : The underdog in healthcare	12/04
Frontier Field Co., Ltd. announced that it has received funding from Terumo Corporation	18/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Terumo Corporation

Actions

4543

JP3546800008

Autres langues

Filtres